University of Gothenburg Study Identifies Nasal Memory Cells That Block Influenza at the Port of Entry

University of Gothenburg study finds that nasal CD4 memory T cells act as a first-line defense against the flu, paving the way for better nasal vaccines.

By: AXL Media

Published: Apr 24, 2026, 3:50 AM EDT

Source: Information for this report was sourced from University of Gothenburg

The First Line of Respiratory Defense

A significant advancement in immunological research has identified a specialized "barricade" of immune cells that remain in the nose following a bout of the flu. Researchers at the Sahlgrenska Academy, University of Gothenburg, have detailed how these CD4 tissue-resident memory T cells provide a rapid, localized response the moment an influenza virus is inhaled. This finding shifts the focus of vaccine research from systemic blood-borne immunity toward the upper respiratory tract, the literal gateway for respiratory infections. By strengthening the immune system exactly where the virus first makes contact, clinicians hope to stop infections before they can migrate to the lungs.

Mechanism of Tissue-Resident Reactivation

The study identifies the CXCR6-CXCL16 axis as the specific biological pathway that promotes the residency of these CD4 cells within nasal tissue. Unlike circulating memory cells that must be recruited from the blood or lymphoid organs—a process that can take several days—these "ready-to-deploy" nasal cells reactivate almost instantly upon re-exposure to the virus. Dr. Nimitha R. Mathew, one of the lead authors, explained that this immediate reactivation allows the immune system to respond directly at the site of entry, significantly curbing the virus's ability to replicate and spread throughout the body.

Bridging the Gap Between Mice and Men

The research was initially conducted using mouse models to observe how these immune cells limit viral levels and prevent nasal tissue damage during secondary infections. To ensure clinical relevance, the team also performed a single-cell RNA-sequencing analysis on nasal mucosa samples from healthy human adults. They discovered the same type of influenza-specific memory cells in the human nasal cavity, specifically a high frequency of Th17 CD4 cells. These cells are known for their ability to aid in viral clearance and promote tissue repair, confirming that a similar localized defense mechanism exists in the human upper respiratory tract.